+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Merrem"

Carbapenem Market Size, Share & Trends Analysis Report By Drug Class (Meropenem, Imipenem, Ertapenem), By Application (UTI, Blood Stream Infections, Pneumonia), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Carbapenem Market Size, Share & Trends Analysis Report By Drug Class (Meropenem, Imipenem, Ertapenem), By Application (UTI, Blood Stream Infections, Pneumonia), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 236 Pages
  • Global
From
Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication, and Distribution Channel - Product Thumbnail Image

Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication, and Distribution Channel

  • Report
  • February 2022
  • 180 Pages
  • Global
From
Merrem PWS IV- Generic sale global - API Insight, 2022 - Product Thumbnail Image

Merrem PWS IV- Generic sale global - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Merrem PWS IV- Drug Insight, 2019 - Product Thumbnail Image

Merrem PWS IV- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Merrem is a brand of antibiotics developed by Merck & Co. It is a broad-spectrum antibiotic used to treat a variety of bacterial infections. Merrem is a semi-synthetic penicillin, meaning it is derived from a natural source, but has been modified to increase its effectiveness. It is used to treat infections caused by susceptible bacteria, including skin and soft tissue infections, respiratory tract infections, and urinary tract infections. Merrem is available in both intravenous and oral formulations. The Merrem market is a competitive one, with a number of companies offering similar products. These include Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. Each company offers a range of antibiotics, including Merrem, to meet the needs of different patients. Show Less Read more